Patient
Information Leaflet
Havrix®
Junior Monodose®
(Hepatitis A) Vaccine
Please read all of this leaflet before this vaccine
is given.
-
Keep this leaflet. You may need to read it
again.
-
If you have further questions, please ask your
doctor or your pharmacist.
In this leaflet:
-
1. What Havrix Junior Monodose is and what it is
used for
-
2. Before having Havrix Junior Monodose
-
3. How Havrix Junior Monodose is given
-
4. Possible side effects
-
5. Storing Havrix Junior Monodose
The name of this vaccine is Havrix Junior
Monodose (hepatitis A) Vaccine
- The
active ingredient in Havrix Junior Monodose is
inactivated hepatitis A virus.
- Other
ingredients are aluminium hydroxide, 2-phenoxyethanol,
polysorbate 20, amino acids for injection, disodium
phosphate, monopotassium phosphate, sodium chloride,
potassium chloride and water for injections.
1. What
Havrix Junior Monodose is and what it is used for
Havrix
Junior Monodose is a vaccine containing hepatitis A
virus.
The virus is
not alive so this vaccine cannot cause hepatitis A
infection. When a person is given Havrix Junior Monodose
vaccine their body will make antibodies (the body’s
natural defence system) against the hepatitis A virus.
These antibodies will protect the person against
hepatitis A infection from about 2 to 4 weeks after the
injection. To ensure long term protection, the
child/teenager should receive a booster vaccination 6 to
12 months after their primary dose. However, as long as
the child/teenager receives the booster within 3 years,
they should still be fully protected. Once the
child/teenager has had their booster vaccination, they
are not expected to need an additional dose of Havrix.
Some general
information on hepatitis A infection is given at the end
of this leaflet.
Having this
vaccine will only protect against hepatitis A and not
against any other type of hepatitis virus or any other
illness that can cause hepatitis (inflammation of the
liver).
Havrix
Junior Monodose is a cloudy white injectable liquid
vaccine in a prefilled syringe that contains a single
0.5 ml dose. Each 0.5 ml dose of the vaccine contains
720 ELISA units of hepatitis A viral protein. The
vaccine is available in packs of 1 or 10 prefilled
syringes.
2.
Before having Havrix Junior Monodose
Havrix Junior Monodose should not be given if the
answer is “Yes” to any of the following:
-
Has the child/teenager ever had an allergic
reaction to any vaccine intended to protect
against hepatitis A infection?
-
Do you think the child/teenager may be allergic
to Havrix Junior Monodose or any of the
ingredients listed previously?
-
Has the child/teenager ever had a severe
allergic reaction to neomycin or any other
antibiotic?
-
Is the person to be vaccinated aged 16 years or
over? A higher dose vaccine is recommended for
people who are aged 16 years and over.
If you
are not sure about the answers to any of these
questions, ask your doctor or nurse.
Havrix Junior Monodose may have to be delayed if the
answer to the following is “Yes”:
-
Does the child/teenager have a severe fever
(high temperature)?
Take
special care with Havrix Junior Monodose
If the
answer is “Yes” to any of the following questions
for the person who is going to receive the vaccine,
talk to your doctor or nurse before the vaccine is
given. Havrix Junior Monodose can still be given,
but the person to be vaccinated may not develop
enough antibody after a single injection to protect
them against infection.
Sometimes, an injection of antibody will be needed
to try to protect the person until the vaccine
starts to work. This can be given at the same time
as they have the vaccine but will be injected into
the opposite arm.
-
Is the person to be vaccinated on dialysis for
kidney disease?
-
Does the person to be vaccinated have a poor
immune system (for example, have they been told
that their immunity to infection is low or are
they taking steroid tablets or other medicines
that can lower their immunity to infections)?
In these
cases, the doctor or nurse may decide that extra
doses of Havrix Junior Monodose should be given and
may take a blood test to measure the antibody levels
in the blood before or after the vaccine is given.
Is it
possible or has the person to be vaccinated already
been told that they may have already been infected
with hepatitis A virus but are not yet showing signs
of the infection? For example, does the person to be
vaccinated live with someone who has got hepatitis A
recently? If so, the vaccine may not be able to
prevent them showing signs of the illness.
In this
case, the doctor or nurse may decide to give an
injection of human antibodies to help prevent them
from having the illness.
Pregnancy
Women
who are pregnant may sometimes be vaccinated. Talk
to your doctor or nurse if the person to be
vaccinated thinks they are, or that they might be,
pregnant.
Breast-feeding
Women
who are breast-feeding may sometimes be vaccinated.
Talk to your doctor or nurse if the person to be
vaccinated is breast-feeding.
Taking/using other medicines
Please
tell your doctor or nurse if the person to be
vaccinated is taking, or has recently taken, any
other medicine. Other vaccines can be given at the
same time as Havrix Junior Monodose. These vaccines
will be given at different injection sites.
3. How
Havrix Junior Monodose is given
Havrix
Junior Monodose (0.5 ml) is injected into the muscle in
the upper arm.
The first
dose of vaccine should protect people with normal
immunity from infection with hepatitis A virus within
2-4 weeks after the injection. Protection should last
for at least 1 year.
To ensure
that protection continues for at least 10 years, a
second (booster) dose of the vaccine should be given 6
to 12 months after the first injection. Having two doses
within 1 year is the best way to make sure that the
person is protected, and that protection will last for
at least 10 years without interruption.
If the date
for the booster injection is missed but a second dose is
given within 3 years of the first dose, protection
against hepatitis A infection should still continue for
at least 10 years.
If a second
dose is not given within 3 years of the first dose, the
doctor may decide that vaccination should start again,
with 2 doses of vaccine within 1 year.
The vaccine
is for people aged 1 to 15 years. Persons who are aged
16 years and over should be given the higher strength
vaccine (Havrix Monodose).
4.
Possible side effects
Like all
medicines, including all vaccines, Havrix Junior
Monodose can have side effects.
Very rarely
some people can have severe allergic reactions after
having the vaccine, these usually happen very soon after
the injection. These can involve difficulty breathing,
tightness in the throat, rapidly spreading rashes,
dizziness, loss of consciousness because of very low
blood pressure, and a very fast heart beat.
These severe
reactions need urgent medical help.
Therefore,
the person who has received Haxrix Junior Monodose may
be asked to stay in the surgery or vaccination area for
a short time after the vaccine has been given to check
that an immediate allergic reaction does not occur.
Please tell your doctor or nurse if the person who has
had Havrix Junior Monodose develops any of these or any
other worrying effects after leaving the clinic, because
it is urgent to get medical help.
Very rarely
some people have had a fit (convulsion) after having the
vaccine. If this happens tell your doctor immediately.
Extremely
rarely there may be reactions involving the nerves. You
should tell your doctor immediately if any of the
following are noticed: pins and needles, loss of feeling
or numbness, problems moving their arms or legs or
difficulty with walking and moving about.
The
commonest side effects are a mild soreness, redness or
hardness at the site of the injection. This should last
only a few days.
Less
commonly the person who has had the vaccine may feel
generally unwell, or have a rash, fever, tiredness,
headache, sickness, diarrhoea or loss of appetite.
Occasionally
tests for liver function can become abnormal for a short
time.
If any side
effects not mentioned in this leaflet are noticed,
please tell your doctor or nurse.
5.
Storing Havrix Junior Monodose
Your doctor
or nurse will usually have supplies of Havrix Junior
Monodose and will have stored it correctly.
However, if
you have been given a prescription for Havrix Junior
Monodose to collect from your pharmacist (chemist), you
should store the vaccine carefully in its outer
container, in a refrigerator between 2°C and 8°C. The
vaccine should not be frozen. The doctor or nurse will
check that the expiry date on the outer package label
has not passed.
Keep Havrix
Junior Monodose out of the reach and sight of
children.on hepatitis A
Hepatitis A
virus causes an infection of the liver. You can catch
the virus by eating or drinking contaminated food or
water. The virus is present in the stools (motions) of
infected people, even when they may have no signs of the
infection. You can catch hepatitis A infection in any
country but the risk is highest in places and countries
where sanitation and food and water hygiene are poor.
After
catching the virus, it can be up to six weeks before
signs of illness are seen. Some people have the virus
and never get ill but they can still infect other people
during this time.
The main
signs of the illness include a headache, fever, sickness
and jaundice (yellowing of the skin and eyes). These
signs are all due to an inflammation of the liver while
it is infected with the virus.
Most
patients get better usually after a couple of months,
but a few people may take up to a year to make a full
recovery. While recovering, people affected with
hepatitis A may be unable to work, they may not be able
to drink alcohol and may need to avoid certain foods
according to their doctors’ advice. Severe complications
are very rare but sometimes the liver stops working and
very special hospital care is needed until the infection
gets better.
There are
many other types of virus that can cause hepatitis. The
signs may be the same as in hepatitis A infection but
the viruses are not always caught through food and
drink. Havrix Monodose can help to protect you against
infection with the hepatitis A virus only.